Consensus document on the use of antibiotic prophylaxis in dental surgery and procedures;Documento de consenso sobre la utilización de profilaxis antibiótica en cirugía y procedimientos dentales

Avances en Odontoestomatologia

Volumn 22, Issue 1, 2006, Pages 41-67

  Gutierrez J L ^a,b   Bagan J V ^a   Bascones, A ^a   Llamas, R ^a   Llena, J ^a   Morales, A ^a   Noguerol, B ^a   Planells, P ^a   Prieto, J ^a   Salmeron J I ^a  

^a Sociedad Española de Cirugía Bucal ^*  (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antibi ticos; Infecciones orales; Profilaxis

Indexed keywords

EID: 77949660375     PISSN: 02131285     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Bascones A, Aguirre JM, Bermejo A, Blanco A, Gay-Escoda C, González-Moles MA, Gutiérrez Pérez JL, Jiménez Soriano Y, Liébaba Ureña J, López-Marcos JF, Maestre Vera JR, Perea Pérez EJ, Prieto Prieto J, de Vicente Rodríguez JC. Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontogénicas. Med Oral Patol Oral Cir Bucal 2004;9:363-76.
2. Prescription des antibiotiques en odontologie et stomatologie. Recommandations et argumentaire. Agence Française de Sé curité Sanitaire des Produits de la Santé. 2001 (www.afssaps.sante.fr).
3. Martínez Lacasa J, Jiménez J, Ferrás VA, García-Rey C, Bosom M, Solá-Morales O, Aguilar L, Garau J. A double blind, placebo-controlled, randosmised, comparative phase III clinical trial of pharmacokinetically enhanced amoxicillin/ clavulanate 2000/125, as prophylaxis or as treatment versus placebo for infectious and inflammatory morbidity after third mandibula removal. Program and Abstracts of the 43rd InterScience Conference on Antimicrobial Agents and Chemotherapy, Chicago 2003. American Society for Microbiology, Washington, DC.
4. Esposito M, Coulthard P, Oliver R, Thomsen P, Worthington HV. Antibiotics to prevent complications following dental implant treatment. Cochrane Database Syst Rev. 2003;3: CD004152.
5. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci. 1998;106: 527-51.
6. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci. 1998;106:721-64.
7. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, McKaig R, Beck J. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol. 1996; 67 (10 Suppl): 1103-13.
8. Overholser CD, Moreillon P, Glauser MP. Experimental bacterial endocarditis after dental extractions in rats with periodontitis. J Infect Dis. 1987;155:107-12.
9. Tomás Carmona I, Diz Dios P, Scully C. An update on the controversies in bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol 2002; 93:660-70.
10. Longman LP, Preston AJ, Martin MV, Wilson NH. Endodontics in the adult patient: the role of antibiotics. J Dent. 2000;28:539-48.
11. Drucker DB, Gomes BP, Lilley JD. Role of anaerobic species in endodontic infection. Clin Infect Dis. 1997; 25 Suppl 2:S220-1.
12. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Evaluation of the mandibular third molar pericoronitis flora and itssusceptibility to different antibiotics prescribed in france. J Clin Microbiol 2003;41:5794-7.
13. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Microbiology of mandibular third molar pericoronitis: incidence of betalactamase-producing bacteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:655-9.
14. Sobottka I, Cachovan G, Sturenburg E, Ahlers MO, Laufs R, Platzer U, Mack D. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother. 2002;46:4019-21.
15. Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001;14:727-52.
16. Okell CC, Elliott D. Bacteremia and oral sepsis with special reference to aetiology of bacterial endocarditis. Lancet 1935;2:869-72.
17. Fine DH, Hammond BF, Loesche WJ. Clinical use of antibiotics in dental practice. Int J Antimicrob Agents. 1998;9:235-8.
18. Jacobson JJ, Patel B, Asher G, Woolliscroft JO, Schaberg D. Oral staphylococcus in older subjects with rheumatoid arthritis. J Am Geriatr Soc. 1997;45: 590-3.
19. Berbari EF, Cockerill FR 3rd, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532-42.
20. Okabe K, Nakagawa K, Yamamoto E. Factors affecting the occurrence of bacteremia associated with tooth extraction. Int J Oral Maxillofac Surg. 1995; 24: 239-42.
21. Rajasuo A, Perkki K, Nyfors S, Jousimies-Somer H, Meurman JH. Bacteremia following surgical dental extraction with an emphasis on anaerobic strains. J Dent Res. 2004; 83:170-4.
22. Stone HH, Haney BB, Kolb LD, et al. Prophylactic and preventive antibiotic therapy: Timing, duration and economic. Ann Surg 1979;189:691-99.
23. Dipiro JT, Cheung RPF, Borden TA Jr. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am J Surg 1986;152:552-9
24. Cisneros JM, Rodríguez-Baño J, Mensa J, et al. Profilaxis con antimicrobianos en cirugía. Enferm Infecc Microbiol Clin 2002;20:335-40.
25. García-Rodríguez JA, Prieto J, Gobernado M, et al. Documento de consenso sobre quimioprofilaxis quirürgica. Rev Esp Quimioterap 2000;13: 205-13.
26. French Health Products Safety Agency (Afssaps). Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol. 2003;17:725-9.
27. Martin MV, Butterworth ML, Longman LP. Infective endocarditis and the dental practitioner: a review of 53 cases involving litigation. Br Dent J. 1997; 182:465-8.
28. Wynn RL, Meiller TF, Crossley H, Overholser CD. Recent reports calling for reduction of antibiotic prophylaxis in dental procedures: a response. Gen Dent. 1999;47:124-30.
29. Aguilar L, García-Rey G, Giménez MJ. Presión antibiótica, desarrollo de resistencias en Streptococcus pneumoniae y fracaso clínico. Un círculo no tan viciosos para algunos antibióticos. Rev Esp Quimioterap 2001;14:17-21.
30. Baquero F, Baquero-Artigao G, Canton R, Garcia-Rey C. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50 (Suppl S2): 27-37.
31. Schrag SJ, Peña C, Fernández J, Sánchez J, Gómez V, Pérez E, Feris JM, Besser RE. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA. 2001;286:49-56.
32. Tong DC, Rothwell BR. Antibiotic prophylaxis in dentistry: a review and practice recommendations. J Am Dent Assoc. 2000; 131: 366-74.
33. Westerman EL. Postsplenectomy sepsis and antibiotic prophylaxis before dental work. Am J Infect Control. 1991;19:254-5.
34. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276-86.
35. Hall G, Heimdahl A, Nord CE. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Eur J Clin Microbiol Infect Dis. 1996;15:646-9.
36. Hall G, Nord CE, Heimdahl A. Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis. J Antimicrob Chemother. 1996;37:783-95.
37. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277:1794-801.
38. Seymour RA, Lowry R, Whitworth JM, Martin MV. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink? Br Dent J. 2000; 189:610-6.
39. Shrout MK, Scarbrough F, Powell BJ. Dental care and the prosthetic joint patient: a survey of orthopedic surgeons and general dentists. J Am Dent Assoc. 1994; 125: 429-36.
40. Altemeier WA, Burke JP, Pruitt BA, Sandusky WR. Manual of control on infection in surgical patients. JB Lippincott Co., Philadelphia 1976.
41. Liñares J, Martin-Herrero JE. Bases farmacomicrobiológicas del tratamiento antibiótico de las enfermedades periodontales y periimplantarias. Av Odontoestomatol 2003; (especial): 23-33.
42. Barberán J, Giménez MJ, Aguilar L, Prieto J. Evidencia científica y concepción global del tratamiento empírico de la infección de vías respiratorias bajas en la comunidad. Rev Esp Quimioterap 2004;17:317-24.
43. Isla A, Canut A, Rodriguez-Gascon A, Labora A, Ardanza-Trevijano B, Solinis MA, Pedraz JL. Análisis farmacocinético/ farmacodinámico (PK/PD) de la antibioterapia en odontoestomatologí a. Enferm Infecc Microbiol Clin. 2005;23:116-21.
44. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother. 2000;46:767-73.
45. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother. 2000;46:959-64.
46. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol. 2002;40:2959-63.
47. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol. 2002 ; 40:159-64.
48. Gomez-Lus R, Granizo JJ, Aguilar L, Bouza E, Gutierrez A, Garcia-de-Lomas J. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. J Clin Microbiol. 1999; 37: 3384-6.
49. Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo JJ. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Antimicrob Agents Chemother. 2005; 49: 820-3.
50. Rodriguez-Avial I, Rodriguez-Avial C, Culebras E, Picazo JJ. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid. Int J Antimicrob Agents. 2003;21:536-41.
51. Tomás I, Limeres J, Diz P. Antibiotic prophylaxis. BDJ 2005;198:60-61.
52. Tomas I, Alvarez M, Limeres J, Otero JL, Saavedra E, Lopez-Melendez C, Diz P. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Oral Microbiol Immunol. 2004;19:331-5.
53. Bascones A, Mansó F. Infecciones odontógenas en la cavidad bucal y región maxilofacial. Av Odontoestomatol 1994;10 (Supl. A):5-26.
54. Tenenbaum JF, Gallion C, Dahan M. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol 1997;24:804-7.
55. Poulet PP, Duffaut D, Barthet P, Brumpt I. Concentrations and in vivo antibacterial activity of spiramycin and metronidazole in patients with periodontitis treated with high-dose metronidazole and the spiramycin/ metronidazole combination. J Antimicrob Chemother 2005;55: 347-51.
56. Isla A, Canut A, Gascon AR, Labora A, Ardanza-Trevijano B, Solinis MA, Pedraz JL. Pharmacokinetic/ Pharmacodynamic evaluation of antimicrobial treatments of orofacial odontogenic infections. Clin Pharmacokinet. 2005; 44(3):305-16.
57. Isla A, Canut A, Rodríguez-Gascón A, Pedraz JL. Farmacocinética/farmacodinámica de la formulación de amoxicilina/ácido clavulánico 2000/125 mg en odontoestomatología. Enferm Infecc Microbiol Clin 2005;23:387.
58. a- ed. Madrid, Interamericana McGraw-Hill. 2002;345-54.
59. a- ed. Madrid, Interamericana McGraw-Hill. 2002;541-59.
60. Mejàre I, Brännström M: Deep bacterial penetration of early proximal caries lesions in young human premolars. J Dent Children 1985; 103-7.
61. Seppä L, Alakuijala P, Karvonen I: A scanning electron microscopic study of bacterial penetration of human enamel in incipient caries. Archs Oral Biol 1985;30:595-8.
62. Bruchner D, Colonna P, Berrazo B. Nomenclatura for aerobic and facultative bacteria. Clin Infect Dis 1999;29:713-23.
63. a- Ed. Madrid, Mosby, 1996;60-128.
64. Pumarola J. Microbiología Endodóntica. En : CANALDA C, BRAU E : Endodoncia. Técnicas clínicas y bases científicas. Barcelona, Masson, 2001;29-41.
65. Figueres KH, Douglas CWI. Actinomycosis associated with a root-treated tooth: report of case. Int Endod J 1991;24:326-9.
66. Molander A, Reit C, Dahlen G, Kvist T. Microbiologicalstatus of root-filled teeth with apical peridontitis. Int Endod J 1998;31:1-7.
67. Barnard D, Davies J, Figdor D. Susceptibility of Actinomyces israelli to antibiotics, sodium hypochlorite and calcium hydroxide. Int Endod J 1996;29:320-6.
68. Vigil GV, Wayman BE, Dazey SE, Fowler CB, Bradley Jr DV. Identification and antaibiotic sensitivity of bacteria isolated from periapical lesions. J Endod 1997;23:110-4.
69. Sands T, Pynn BR, Nenniger S. Third molar surgery: current concepts and controversies. Part 2. Oral Health 1993; 83:19, 21-2, 27-30.
70. Zeitler DL. Prophylactic antibiotics for third molar surgery: a dissenting opinion. J Oral Maxillofac Surg 1995;53:61-4.
71. Kaziro GS. Metronidazole (Flagyl) and Arnica Montana in the prevention of post-surgical complications, a comparative placebo controlled clinical trial. Br J Oral Maxillofac Surg 1984;22: 42-9.
72. Mitchell DA. A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery. Br Dent J 1986;160:284-6.
73. Macgregor AJ, Addy A. Value of penicillin in the prevention of pain, swelling and trismus following the removal of ectopic mandibular third molars. Int J Oral Surg 1980;9:166-72.
74. Piecuch JF, Arzadon J, Lieblich SE. Prophylactic antibiotics for third molar surgery: a supportive opinion. J Oral Maxillofac Surg 1995;53:53-60.
75. Esposito M, Coulthard P, Oliver R, Thomsen P, Worthington HV. Antibiotics to prevent complications following dental implant treatment. The Cochrane Database of Systematic Reviews 2003.
76. Gynther G, Kondell P, Moberg L, Heimdahl A. Dental implant installation without antibiotic prophylaxis. Oral Sug Oral Med Oral Pathol Oral Radiol Endo 1998;85:509-11.
77. Binanhmed A, Stoykewych A, Peterson L. Single preoperative dose versus long-term prophylactic antibiotic regimens in dental implant surgery. Int J Oral Maxillofac Implants 2005;20:115-7.
78. Sindet-Pedersen. The prophylactic use of antibiotics in periodontics. In Proceedings of the 2nd European Workshop on Periodontology. Quintassence. Berlin. 1997:30-7.
79. Daly C, Mitchell D, Grossberg D, Highfield J, Stewart D. Bacteraemia caused by periodontal probing. Aust Dent J 1997;42:77-80.
80. Daly CG, Mitchell DH, Highfield JE, Grossberg DE, Stewart D. Bacteremia due to periodontal probing: a clinical and microbiological investigation. Periodontol 2001;72:210-4.
81. Bowersock TL, Wu CC, Inskeep GA, Chester ST. Prevention of bacteremia in dogs undergoing dental scaling by prior administration of oral clindamycin or chlorhexidine oral rinse. J Vet Dent 2000;17:11-6.
82. Allison C, Simor AE, Mock D, Tenenbaum HC. Prosol-chlorhexidine irrigation reduces the incidence of bacteremia during ultrasonic scaling with the Cavi-Med: a pilot investigation. J Can Dent Assoc 1993;59:676-82.
83. Lofthus JE, Waki MY, Jolkovsky DL, Otomo-Corgel J, Newman MG, Flemmig T, Nachnani S. Bacteraemia following subgingival irrigation and scaling and root planing. J Periodontol 1991;62: 602-7.
84. Witzenberger T, O'Leary TJ, Gillette WB. Effect of a local germicide on the occurrence of bacteremia during subgingival scaling. J Periodontol 1982;53:172-9.
85. Appleman MD, Sutter VL, Sims TN. Value of antibiotic prophylaxis in periodontal surgery. J Periodontol. 1982 May; 53(5):319-24.
86. Powell CA, Mealey BL, Deas DE, McDonnell HT, Moritz AJ. Post-surgical infections: prevalence associated with various periodontal surgical procedures. J Periodontol 2005;76:329-33.
87. Wampole HS, Allen AL, Gross A. The incidence of transient bacteremia during periodontal dressing change. J Periodontol 1978;49:462-4.
88. Schlein RA, Kudlick EM, Reindorf CA, Gregory J, Royal GC. Tootbrushing and transient bacteraemia in patients undergoing orthodontic treatment. Am J Orthod Dentof Orthop 1991;99:466-72.
89. Sconyers JR, Crawford JJ, Moriarity JD. Relationship of bacteraemia to toothbrishing in patients with periodontitis. J Am Dent Assoc 1971;83:1294-6.
90. Bender IB, Naidorf IJ, Garvey GJ, Bacterial endocarditis: a consideration for physicians and dentists. J Am Dent Assoc 1984;109:415-20.
91. Everett ED, Hirschmann JV. Transient bacteraemia and endocarditis prophylaxis: a review. Medicine 1977;56:61-77.
92. Guntheroth WG. How important are dental procedures as a cause of infective endocarditis? Am J Cardiol 1984; 54: 797-801.
93. Schroeder HE, Theilade J. Electrón microscopy of normal human gingival epithelium. J Perio Res 1966;1:95-119.
94. Lockhart PB. The risk for endocarditis in dental practice. Periodontology 2000 2000;23:127-35.
95. Seiham A, Netuvelli GS. Periodontal diseases in Europe. Periodontology 2000 2002;29:104-21.
96. Roberts GJ, Holzel HS, Sury MRJ, Simmons NA, Gardner P, Longhurst P. Dental bacteremia in children. Pediatr Cardiol 1997;18:24-7.
97. Khurana M, Martin MV. Orthodontics and Infective Endocarditis. Br J Orthodontics 1999;26:295-8.
98. Roberts GJ, Simmons NB, Longhurst P, Hewitt PB. Bacteraemia following local anaesthetic injections in children. Br Dent J 1998;185:295-8.
99. Guggenheimer J, Orchard TJ, Moore PA, Myeres DE, Rossie KM. Reliability of self-reported heart murmur history: possible impact on antibiotic use in dentistry. JADA 1998;129:861-6.